medline.ch Onkologie Gynäkologische Tumoren

	Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer. PLoS One Song SG, Cho SI, Sim T, Shin S, Jung W, Shin J, Kim S, Song H, Pereira S, Yoo D, Baek SK, Na K, Jung M, Kim SW. PMID: 42406760 [PubMed - indexed for MEDLINE]
	An Explainable AI-Based Transfer Learning Method for Breast Cancer Prediction. J Vis Exp Rajeswari P, Khan SB, S PP, R MT, Algarni A, Almusharraf A. PMID: 42406752 [PubMed - indexed for MEDLINE]
	Age and tumor size as independent predictors of malignancy in BI-RADS 4 and 5 breast lesions: A cross-sectional study in Vietnam. PLoS One Nguyen V, Pham TV, Dinh TH, Tran DN, Dang CT. PMID: 42406726 [PubMed - indexed for MEDLINE]
	Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series. J Drugs Dermatol Huggins LK, Manjunath J, Alorainy M, Leventhal JS, Deverapalli S. PMID: 42406353 [PubMed - indexed for MEDLINE]
	Omission of Axillary Surgery in Patients with Invasive Lobular Carcinoma of the Breast: Rates of Nodal Involvement in Clinically Node Negative Patients and Impact on Recurrence in a Single Institution Analysis. Ann Surg Oncol Abeles E, Shui AM, Quirarte A, Barkin J, Choi S, Chen Y, Huppert L, Kim N, Moya J, Vertido A, Mukhtar RA. PMID: 42406219 [PubMed - as supplied by publisher]
	Potential Impact of Sentinel Lymph Node Biopsy Omission on Adjuvant Treatment Decisions in Low-Risk Breast Cancer: A Regional Multicenter 775 Patient Review of Current Practice in the United Kingdom. Ann Surg Oncol Campbell EJ, Doughty L, Sakellariou S, Trafford P, Trafford J, Romics L, Mansell J. PMID: 42406215 [PubMed - as supplied by publisher]
	Axillary Recurrence and Survival After Omission of Axillary Lymph Node Dissection inÂ Patients with Breast Cancer and Micrometastases or Isolated Tumor Cells in the Sentinel Node: A Danish National Register Study. Ann Surg Oncol Korsholm RHR, Kroman N, Tvedskov TF, Munck F. PMID: 42406208 [PubMed - as supplied by publisher]
	Experiences of implementation of personalised risk estimates for breast cancer in clinical practice: a systematic review and qualitative synthesis. J Community Genet Fennell NB, Abukar S, Kuhn I, Linneker P, Wilson C, Tischkowitz M, Archer S. PMID: 42405977 [PubMed]
	Patients' expectations and barriers towards postoperative telehealth follow-up after oncologic breast surgery in France. Support Care Cancer Prevost S, Mazellier S, Weitbruch D, Lodi M. PMID: 42405962 [PubMed - indexed for MEDLINE]
	Supporting patient understanding of cervical and ovarian cancer: how well does AI perform? Proc (Bayl Univ Med Cent) Shin R, Shin A, Ramirez M, Bondre IL, Aviles DJ, Nugent EK. PMID: 42405834 [PubMed - as supplied by publisher]
	Experiences of Women who do not Participate in Breast Cancer Screening Programs: A Qualitative Study. Public Health Nurs Durmaz NK, Gençtürk N. PMID: 42405655 [PubMed - as supplied by publisher]
	2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management. J Breast Cancer Lai JI, Hung CC, Lin CY, Li CL, Chung WP, Lin CH, Yu CP, Wang MY, Chu SC, Wu CT, Lee KT, Sheen-Chen SM, Yu JC, Hong ZJ, Hung CM, Hung CS, Chang KJ, Chang CH, Chang YC, Chang HK, Chang DY, Chang YJ, Kuo WH, Kuo WL, Chen ST, Chen IC, Chen FM, Chen SC, Chen WW, Chen DR, Tseng LM, Tzeng YD, Huang CC, Huang CS, Yeh HT, Liao GS, Chao TC, Chao TY, Liu LC, Liu CY, Tsai CH, Cheng FT, Lu YS, Dai MS, Chung CF, Rau KM. PMID: 42405610 [PubMed]
	Ovarian Function Suppression in Premenopausal Hormone Receptor-Positive Early Breast Cancer: A Comprehensive Review. J Breast Cancer Park WK, Ryu JM. PMID: 42405609 [PubMed]
	Advances in the design and discovery of small-molecule tyrosine kinase inhibitors for breast cancer. RSC Adv Elwaie TA, Aref MMA, Ali HI. PMID: 42405118 [PubMed - as supplied by publisher]
	Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity. Breast Cancer (Dove Med Press) Yi G, Deng L, Su L, Jie H, Huang C, Wang Y. PMID: 42404859 [PubMed]
	ED50 and ED95 of Remimazolam Combined with Sufentanil for Sedation During Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Prospective Dose-Finding Study. Drug Des Devel Ther Wei A, Ou L, Chen Y, Chen M, Wei F, Mo X. PMID: 42404707 [PubMed - indexed for MEDLINE]
	Construction of an ultrasound feature-based diagnostic model for predicting triple-negative breast cancer using 108 machine learning algorithm combinations. J Clin Imaging Sci Zhang X, Zhang X, Zhu S, Ao N, Cao Y, Yang G. PMID: 42404642 [PubMed]
	Next-Generation CDK Inhibitors in Breast Cancer: Expanding the Therapeutic Landscape beyond CDK4/6 Inhibitors. Breast Care (Basel) Wu J, Lai Y, Lu G. PMID: 42404635 [PubMed - as supplied by publisher]
	Development and Validation of a Pathomics Model for Prognosis Prediction in Neoadjuvant Therapy-Treated Breast Cancer: A Retrospective, Multicenter Study. MedComm (2020) Wei Y, Lou W, Han Z, Yang F, Li F, Li H, Shi H, Wei B, Li H, Zhao Y, Xiao X, Yang Y, Han A, Yao J, Bu H. PMID: 42404588 [PubMed]
	Transcutaneous electrical acupoint stimulation for intercostobrachial nerve syndrome after breast cancer surgery: a randomized controlled trial protocol. Front Glob Womens Health Xia Q, Wu L, Sun Y, Li S, Hu X, Liang Z, Zhang Z, Jiang A, Zhao R. PMID: 42404389 [PubMed]

Artikel 1 - 20 / 331660

Seite 1 von 16583

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung